1. Home
  2. TREX vs LEGN Comparison

TREX vs LEGN Comparison

Compare TREX & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TREX
  • LEGN
  • Stock Information
  • Founded
  • TREX 1996
  • LEGN 2014
  • Country
  • TREX United States
  • LEGN United States
  • Employees
  • TREX N/A
  • LEGN N/A
  • Industry
  • TREX
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TREX
  • LEGN Health Care
  • Exchange
  • TREX Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • TREX 6.4B
  • LEGN 6.7B
  • IPO Year
  • TREX 1999
  • LEGN 2020
  • Fundamental
  • Price
  • TREX $60.47
  • LEGN $33.11
  • Analyst Decision
  • TREX Buy
  • LEGN Strong Buy
  • Analyst Count
  • TREX 14
  • LEGN 12
  • Target Price
  • TREX $71.93
  • LEGN $73.36
  • AVG Volume (30 Days)
  • TREX 1.4M
  • LEGN 1.1M
  • Earning Date
  • TREX 10-27-2025
  • LEGN 11-11-2025
  • Dividend Yield
  • TREX N/A
  • LEGN N/A
  • EPS Growth
  • TREX N/A
  • LEGN N/A
  • EPS
  • TREX 1.73
  • LEGN N/A
  • Revenue
  • TREX $1,129,138,000.00
  • LEGN $796,838,000.00
  • Revenue This Year
  • TREX $8.91
  • LEGN $70.75
  • Revenue Next Year
  • TREX $7.50
  • LEGN $52.47
  • P/E Ratio
  • TREX $35.94
  • LEGN N/A
  • Revenue Growth
  • TREX N/A
  • LEGN 74.75
  • 52 Week Low
  • TREX $49.01
  • LEGN $27.34
  • 52 Week High
  • TREX $80.74
  • LEGN $52.31
  • Technical
  • Relative Strength Index (RSI)
  • TREX 45.79
  • LEGN 36.16
  • Support Level
  • TREX $59.69
  • LEGN $33.20
  • Resistance Level
  • TREX $62.45
  • LEGN $34.71
  • Average True Range (ATR)
  • TREX 1.75
  • LEGN 1.22
  • MACD
  • TREX -0.21
  • LEGN -0.09
  • Stochastic Oscillator
  • TREX 19.03
  • LEGN 10.96

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: